Cost Effectiveness of Lacosamide in the Adjunctive Treatment of Patients with Refractory Focal Epilepsy in Belgium

被引:0
|
作者
Steven Simoens
Liesbet De Naeyer
Peter Dedeken
机构
[1] Katholieke Universiteit Leuven,Research Centre for Pharmaceutical Care and Pharmacoeconomics
[2] UCB Pharma,undefined
来源
CNS Drugs | 2012年 / 26卷
关键词
Seizure Frequency; Lacosamide; Pivotal Trial; Seizure Freedom; Seizure Reduction;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives: Lacosamide is an anti-epileptic drug, indicated as adjunctive therapy for patients with focal seizures with or without secondary generalization. This study aims to assess the cost effectiveness of standard antiepileptic drug therapy plus lacosamide 300 mg/day compared with standard therapy alone from the perspective of the Belgian healthcare payer.
引用
收藏
页码:337 / 350
页数:13
相关论文
共 50 条
  • [1] Cost Effectiveness of Lacosamide in the Adjunctive Treatment of Patients with Refractory Focal Epilepsy in Belgium
    Simoens, Steven
    De Naeyer, Liesbet
    Dedeken, Peter
    CNS DRUGS, 2012, 26 (04) : 337 - 350
  • [2] COST-EFFECTIVENESS OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN TURKEY
    Benhaddi, H.
    Tabak, G.
    VALUE IN HEALTH, 2013, 16 (03) : A109 - A109
  • [3] Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy
    Kim, Jon Soo
    Kim, Hunmin
    Lim, Byung Chan
    Chae, Jong-Hee
    Choi, Jieun
    Kim, Ki Joong
    Hwang, Yong Seung
    Hwang, Hee
    BRAIN & DEVELOPMENT, 2014, 36 (06): : 510 - 515
  • [4] THE COST-EFFECTIVENESS OF ADJUNCTIVE TREATMENT WITH LACOSAMIDE IN PATIENTS WITH UNCONTROLLED PARTIAL EPILEPSY
    Berggren, F.
    Bolin, K.
    Germe, M.
    Forsgren, L.
    EPILEPSIA, 2009, 50 : 97 - 97
  • [5] Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures
    Garcia-Morales, Irene
    Toledano Delgado, Rafael
    Falip, Merce
    Campos, Dulce
    Eugenia Garcia, Maria
    Gil-Nagel, Antonio
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (10): : 801 - 804
  • [6] Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China
    Shunan Chen
    Fengqian Mao
    Yani Hu
    Suhong Wang
    Jie Chen
    Jiali Zhang
    Lingyan Yu
    Haibin Dai
    International Journal of Clinical Pharmacy, 2025, 47 (2) : 373 - 381
  • [7] EFFICACY AND TOLERABILITY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH PHARMACORESISTANT FOCAL EPILEPSY
    Cappanera, S.
    Cesaroni, E.
    Zamponi, N.
    EPILEPSIA, 2011, 52 : 112 - 112
  • [8] Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
    Hou, Liyan
    Peng, Bingjie
    Zhang, Defu
    Yang, Jingjing
    Wang, Ying
    Tong, Li
    Li, Sheng
    Wang, Qingshan
    Zhao, Jie
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [9] Lacosamide treatment in the adult patients with focal epilepsy
    Toyota, T.
    Sennari, Y.
    Kobata, M.
    Okada, K.
    Adachi, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 692 - 692
  • [10] EFFECTIVENESS OF LACOSAMIDE FOR THE TREATMENT OF NON-CONTROLLED FOCAL EPILEPSY
    Morita, M. E.
    Psaltikidis, E. M.
    Soares, E.
    Cendes, F.
    Yasuda, C. L.
    Evangelista-Poderoso, R.
    Resende, M. R.
    Betting, L. E.
    VALUE IN HEALTH, 2017, 20 (09) : A886 - A886